Access cutting-edge triple-negative breast cancer treatment through this clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.
Access triple-negative breast cancer specialists in Dallas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related triple-negative breast cancer treatment provided free
The purpose of this study is to determine the impact of pre-operative cryoablation, and immune checkpoint inhibition (ICI) on on 3-year Event Free Survival (EFS), in women with residual hormone receptor negative, HER2-negative ("triple negative") resectable breast cancer after taxane-based neoadjuvant chemotherapy.
Sponsor: University of Texas Southwestern Medical Center
Check if you qualify for this triple-negative breast cancer clinical trial in Dallas, TX
If you're searching for triple-negative breast cancer treatment options in Dallas, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dallas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced triple-negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.